Shanghai Bao Pharmaceutical and Subsidiary Secure Commercialization Rights Deal for SJ02 with Organon China
Shanghai Bao Pharmaceutical, a Chinese pharmaceutical company, along with its wholly-owned subsidiary Suzhou Centergene Pharmaceuticals,...
Shanghai Bao Pharmaceutical, a Chinese pharmaceutical company, along with its wholly-owned subsidiary Suzhou Centergene Pharmaceuticals,...
ChemPartner Pharmatech Co., Ltd (SHE: 300149), a leading pharmaceutical company based in China, has joined...
Nona Biosciences, a subsidiary of HBM Holdings Ltd (HKG: 2142), has entered into a strategic...
MoleculeMind, a Beijing-based AI protein design platform, has reportedly secured a Series A financing round,...
Autobio Diagnostics Co., Ltd (SHA: 603658), a prominent player in China’s in vitro diagnostic market,...
Luye Pharma Group (HKG: 2186), a leading pharmaceutical company based in China, has announced a...
Signet Therapeutics, a pioneering biopharmaceutical company in China specializing in cancer targeted therapies based on...
CSA Medical Inc., a U.S.-based medical technology company, has successfully closed a Series D financing...
Gilead Sciences Inc. (NASDAQ: GILD), a biopharmaceutical company based in the U.S., has entered into...
Carisma Therapeutics Inc. (NASDAQ: CARM), a U.S.-based company specializing in chimeric antigen receptor (CAR) macrophage...
Itcure, a prominent gene editing specialist headquartered in Suzhou, has announced separate strategic collaborations with...
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd (HKG: 1541) has announced the receipt of a further payment...
Beijing Centergate Technologies (Holding) Co., Ltd (CENTEK, SHE: 000931), a pharmaceutical manufacturing company in China,...
Chengdu Kanghua Biological Products Co., Ltd (SHE: 300841), a biopharmaceutical company based in China, has...
JHM Biopharma, a protein drug developer based in Hangzhou, has reportedly secured over RMB 200...
Candel Therapeutics, Inc. (CADL), a U.S.-based biopharmaceutical company, has announced the acquisition of two U.S....
Insilico Medicine, a leading artificial intelligence-driven drug discovery company based in China, has announced a...
Tigermed (SHE: 300347), a leading Contract Research Organization (CRO) in China, has entered into a...
Edwards Lifesciences, a leading U.S. medical device company, has reportedly reached an agreement to sell...
Caprico Biotechnologies, Inc., a Chinese biotechnology company, has entered into a comprehensive partnership with Mindray...